PMC:6909918 / 36851-37011 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/PMC/sourceid/6909918","sourcedb":"PMC","sourceid":"6909918","source_url":"https://www.ncbi.nlm.nih.gov/pmc/6909918","text":"* The RECOURSE Trial [5] enrolled some patients previously treated with regorafenib (17% patients in the TAS-102 group, and 20% patients in the placebo group).","divisions":[{"label":"label","span":{"begin":0,"end":1}}],"tracks":[]}